Funder: National Institutes of Health
Due Dates: February 19, 2025 (Letter of Intent) | March 19, 2025 (AIDS applications) | March 19, 2026 (AIDS applications)
Funding Amounts: Up to $350,000 direct costs per year, for up to 5 years (R01 mechanism); total program funds ~$3M/year for 6–7 awards (R01/R21 combined)
Summary: Supports data mining and functional validation studies using single cell datasets to identify and test molecular mechanisms underlying HIV/ART and substance use disorder (SUD) responses.
Key Information: Clinical trials are not allowed; applications must address both HIV/ART and SUD molecular responses using single cell data.